irány Divatot utánzó Akinek hepatic steatosis as a marker of metabolic dysfunction Ütközés tanfolyam Erő Oroszország
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients | Molecular Systems Biology
JCM | Free Full-Text | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis | Semantic Scholar
CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression | Science Advances
A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study | Scientific Reports
PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction
PDF] Hepatic Steatosis as a Marker of Metabolic Dysfunction | Semantic Scholar
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology & Metabolic Syndrome | Full Text